Madison Grace Nowell

Madison Nowell practices at TMH Physician Partners in Tallahassee, Florida.

Madison Nowell's NPI, 1275270365, was assigned on May 19, 2022. Madison Nowell holds Alabama license 1-155391.

Madison Nowell's primary practice is TMH Physician Partners, at 1607 St James Ct, Tallahassee, FL 32308. The practice phone is (850) 431-6200.

Madison Nowell's primary practice is TMH Physician Partners in Tallahassee, Florida. Madison Nowell is also affiliated with Flowers Hospital. The medical group on file is TMH Physician Partners. Dmand AI also links Madison Nowell to 2 more hospitals, 3 group practices and clinics, 2 medical groups and 1 urgent care center, each named with a free account. Madison Nowell's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Madison Nowell practices, 8 sites in all. Vendor and product names are available with a free account.

Family is Madison Nowell's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Madison Nowell is licensed in Alabama.

Dmand AI lists acute skin infection, ankle or foot injury, arthritis, chronic diabetes, contact dermatitis, head wound, joint or bone infection and minor injury to a limb among the conditions Madison Nowell treats.

CMS data shows 788 Medicare services from Madison Nowell across 8 procedure codes in 2024, for 135 Medicare patients. Medicare paid $30,420 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 135 Medicare patients who saw Madison Nowell in 2024. The largest group is 75 to 84, with 43 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Madison Nowell's median patient age at 72, with 48% women.

In 2024, Madison Nowell wrote 335 Medicare Part D claims for 135 patients. 90% of them were for generic drugs. CMS names the drug for 244 of them, across 9 drugs with 11 or more claims each, at $17,521 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Madison Nowell for performance year 2024, reported through an alternative payment model (APM). Madison Nowell accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 67 general payments to Madison Nowell from 16 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Organogenesis Inc. paid the most, $338.